Key result
PCOS is linked to chronic low-grade inflammation, especially alongside obesity, insulin resistance, and hyperandrogenism.
Why the study?
Inflammation has been implicated in the metabolic disturbances and menstrual irregularities of PCOS, but the role of cytokines and potential anti-inflammatory treatments requires clarification.
Answers are grounded in this paper and cite their sources.
PCOS is characterized by a chronic low-grade inflammatory state, suggesting that targeting inflammation with anti-inflammatory agents could be a potential therapeutic strategy.
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women of reproductive age. Inflammation has been implicated in the metabolic disturbances and menstrual irregularities, which characterize this condition. Various inflammatory proteins have been investigated in women with PCOS including C-reactive protein, interleukin-6, interleukin-18 and tumor necrosis factor-alpha. The data is suggestive of the presence of a chronic low-grade inflammatory state, especially in case of obesity, insulin resistance and hyperandrogenism. Targeting this inflammatory process by means of anti-inflammatory agents might be a therapeutic alternative to the current treatment.
No takes yet. Share an insight, caveat, or question.
Ebejer et al. (2013) conducted a review in Polycystic ovarian syndrome (PCOS). Inflammation and cytokines was evaluated. Chronic low-grade inflammation, characterized by various inflammatory proteins, is present in women with PCOS, especially in cases of obesity, insulin resistance, and hyperandrogenism.
Synapse has enriched 10 related papers. Consider them for comparative context: